FindTrial
Sign In

The Effectiveness and Safety of Continuous Intravenous Pumping Muscle Relaxants:A Randomized Clinical Study.

The Effectiveness and Safety of Continuous Intravenous Pumping Muscle Relaxants:A Randomized Clinical Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006169
Enrollment
Unknown
Registered
2015-04-01
Start date
2015-04-07
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Residual Paralysis

Interventions

A1:Muscle Relaxant: Cisatracurium
A2:Muscle Relaxant: Cisatracurium
B1:Muscle Relaxant: Rocuronium
B2:Muscle Relaxant: Rocuronium
C1:Muscle Relaxant: Mivacurium
C2:Muscle Relaxant: Mivacurium

Sponsors

ZhuJiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Age 18~65 years; (2)ASA I~II; (3)BMI=4h).

Exclusion criteria

Exclusion criteria: (1)Patients who are sufferring nerve-muscle diseases; (2)Patients with difficult airway; (3)Pregnant woman or breast feeding women; (4)The position is inadequate; (5)Allergic to gel electrode.

Design outcomes

Primary

MeasureTime frame
the data of train-of-four stimulation;Recoveryindex (T1 25~75);—

Secondary

MeasureTime frame
Arterial blood gas analysis;Extubation time;dosage;operating time;anesthesia time;—

Countries

China

Contacts

Public ContactShiyuan Xu
xushiyuan355@163.com+86 020-61643298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026